M. Diamant et al., STIMULATION OF THE B9 HYBRIDOMA CELL-LINE BY SOLUBLE INTERLEUKIN-6 RECEPTORS, Journal of immunological methods, 173(2), 1994, pp. 229-235
Interleukin-6 (IL-6) exerts its effects by binding to specific recepto
rs on the cell surface. The IL-6 receptor consists of at least two com
ponents, a ligand binding 80 kDa low-affinity component (IL-6R) and a
signal-transducing non-ligand binding 130 kDa component (gp130). The p
resence of soluble forms of these components has been described in bot
h conditioned media and biological fluids. The soluble (s) IL-6R has b
een shown to enhance the IL-6 sensitivity of several both murine and h
uman IL-6 sensitive cell types. A sensitive and commonly used method f
or measuring biological IL-6 activity is based on the IL-6 dependent p
roliferation of the murine hybridoma cell line B9. In this paper, we d
emonstrate that recombinant (r) human (h) sIL-6R enhances the sensitiv
ity of B9 cells in a dose-dependent manner. The rhsIL-6R enhanced the
binding of I-125-rhIL-6 to B9 cells. The rhsIL-6R induced stimulation
of B9 proliferation was maximal at 100 ng/ml, even without addition of
rhIL-6 and in the presence of anti-hIL-6 antibodies. This may be due
to endogenous IL-6 production by the B9 cells, low levels of IL-6 in t
he fetal calf serum used, or perhaps an IL-6 independent effect by the
rhsIL-6R. In conclusion, this and other reports point to the necessit
y of confirming measured biological activities through the use of neut
ralizing specific antibodies or parallel measurements in immunochemica
l assays.